迪瑞医疗收盘上涨1.21%，滚动市盈率25.81倍，总市值36.62亿元

Company Overview - Di Rui Medical closed at 13.43 yuan on April 21, with an increase of 1.21%, and a rolling PE ratio of 25.81 times, resulting in a total market capitalization of 3.662 billion yuan [1] - The company ranks 64th in the medical device industry, which has an average PE ratio of 47.69 times and a median of 29.88 times [1][2] - Di Rui Medical specializes in the research, production, marketing, and service of medical testing instruments and related reagents, with key products including urine analysis, biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and overall laboratory solutions [1] Financial Performance - For the latest fiscal year 2024, Di Rui Medical reported a revenue of 1.218 billion yuan, a year-on-year decrease of 11.63%, and a net profit of 142 million yuan, down 48.50% year-on-year, with a gross profit margin of 43.84% [1] Capital Flow - On April 21, the net outflow of main funds for Di Rui Medical was 1.7783 million yuan, with a total outflow of 13.2825 million yuan over the past five days [1]